de Macedo Priscila Marques, Almeida-Paes Rodrigo, de Medeiros Muniz Mauro, Oliveira Manoel Marques Evangelista, Zancopé-Oliveira Rosely Maria, Costa Regina Lana Braga, do Valle Antonio Carlos Francesconi
Laboratório de Pesquisa Clínica em Dermatologia Infecciosa, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21045-900, Brazil.
Laboratório de Micologia, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Mycopathologia. 2016 Oct;181(9-10):701-8. doi: 10.1007/s11046-016-0015-6. Epub 2016 May 9.
Paracoccidioidomycosis (PCM) is a systemic mycosis caused by pathogenic dimorphic fungi of the Paracoccidioides brasiliensis complex. It is the most important systemic mycosis in Latin America, mainly in Brazil. Despite its severity and high mortality rates, it is considered a neglected disease. Species within the genus Paracoccidioides present genetics and morphological variations with probable clinical, diagnostic and therapeutic consequences. In fact, there are a very small number of detailed case reports with molecular identification of these fungal agents. Here, it is reported a case of PCM due to Paracoccidioides brasiliensis PS2. Molecular identification of the isolate was performed by amplification and sequencing of the arf and gp43 genes. Clinical cases and strain reports with molecular identification in the literature are also reviewed. The case herein presented is the first autochthonous report of PCM due to Paracoccidioides brasiliensis PS2 species in the state of Rio de Janeiro, Brazil, an important endemic area. The patient presented a chronic pulmonary form of PCM and had a satisfactory response to sulfamethoxazole/trimethoprim although sequelae such as adrenal insufficiency and dysphonia were observed. This study may contribute to improve the knowledge about this severe disease, its causative cryptic species and their consequences to patients.
副球孢子菌病(PCM)是一种由巴西副球孢子菌复合体的致病性双相真菌引起的系统性真菌病。它是拉丁美洲,主要是巴西最重要的系统性真菌病。尽管其严重性和高死亡率,但它仍被视为一种被忽视的疾病。副球孢子菌属内的物种存在遗传和形态变异,可能会对临床、诊断和治疗产生影响。事实上,对这些真菌病原体进行分子鉴定的详细病例报告数量非常少。在此,报告一例由巴西副球孢子菌PS2引起的PCM病例。通过对arf和gp43基因进行扩增和测序,对分离株进行分子鉴定。还对文献中具有分子鉴定的临床病例和菌株报告进行了综述。本文介绍的病例是巴西里约热内卢州(一个重要的流行地区)首例由巴西副球孢子菌PS2物种引起的PCM本地病例报告。该患者表现为慢性肺部型PCM,对磺胺甲恶唑/甲氧苄啶有满意的反应,尽管观察到了肾上腺功能不全和发音障碍等后遗症。本研究可能有助于提高对这种严重疾病、其致病性隐匿物种及其对患者影响的认识。